胃食管反流药与痴呆风险;EB病毒与IBD关联;肝δ病毒管理
Reflux Drugs and Dementia Risk; Epstein-Barr's Link to IBD; Managing Hepatitis Delta
研究发现,质子泵抑制剂使用与老年人痴呆风险轻度增加相关。Sucralfate在治疗慢性肛裂方面疗效优于硝酸甘油,显著提高愈合率。Mirum Pharmaceuticals计划寻求FDA批准其针对慢性肝δ病毒的抗体药物。
— News and commentary from the world of gastroenterology and hepatology
by Ian Ingram, Managing Editor, MedPage Today
November 12, 2026 • 2 min read
Use of proton pump inhibitors in older adults was associated with a modestly increased risk of incident dementia, according to a meta-analysis of nearly two dozen studies published in Clinical Pharmacology and Therapeutics.
And watch out for the increased pancreatic cancer risk in patients with PRSS1-associated hereditary pancreatitis, researchers warned. (Clinical Gastroenterology and Hepatology)
Mouse research suggested that antibodies in the gut, immunoglobulin A specifically, may help protect against colorectal cancer. (Nature)
Sucralfate topped nitroglycerin in a randomized trial of topical agents for chronic anal fissures, more than doubling healing rates within 2 weeks. (American Journal of Gastroenterology)
Real-world data favored the JAK inhibitor tofacitinib (Xeljanz) over the TNF inhibitor infliximab (Remicade) for 1-year remission rates in ulcerative colitis patients already exposed to advanced therapies. (Inflammatory Bowel Diseases)
Pretreatment serum glycoprotein acetylation can predict early relapse risk in Crohn's disease patients who stop infliximab, an analysis of blood samples showed. (Gastroenterology)
Research in Inflammatory Bowel Diseases examined links between Epstein-Barr virus and inflammatory bowel disease (IBD).
Lipid profile analysis of upadacitinib (Rinvoq)-treated IBD patients showed modest increases in cholesterol that researchers said warrants monitoring. (Inflammatory Bowel Diseases)
A single-center U.S. study offered reassurance on the safety and effectiveness of assisted reproductive technology for women with IBD. (Inflammatory Bowel Diseases)
Everything you ever wanted to know about diagnosing and managing hepatitis delta virus infections. (Hepatology)
Speaking of the virus, Mirum Pharmaceuticals announced plans to seek FDA approval for its investigational monoclonal antibody brelovitug in chronic hepatitis D after detailing a second positive phase III trial.
U.S. patients with alcohol-associated liver disease who underwent liver transplantation lived years longer, according to a claims-based study that also revealed sex and racial disparities in access to transplant. (Alcohol, Clinical and Experimental Research)
Atrial fibrillation, venous thrombosis? Indication matters when choosing between anticoagulants for patients with cirrhosis, a nationwide U.S. cohort study suggested. (Clinical Gastroenterology and Hepatology)
Also in cirrhosis, a prospective multicenter cohort linked sedatives to a risk for falls, hospitalization, and overt hepatic encephalopathy. (Clinical Gastroenterology and Hepatology)
In a European study of transjugular intrahepatic portosystemic shunt for refractory hepatic hydrothorax, complete responses -- achieved in 60% of the sample -- were associated with improved survival. (Clinical Gastroenterology and Hepatology)
A remote post-discharge management program may reduce the risk of liver-related hospitalization in patients with acutely decompensated cirrhosis, according to observational data. (Hepatology)
Looking for more in hepatology? Check out our coverage of the annual Liver Meeting sponsored by the American Association for the Study of Liver Diseases.
来源:MedPage Today · medpagetoday.com